Labcorp Holdings Inc. (LH) is a publicly traded Healthcare sector company. As of October 8, 2026, LH trades at $312.15 with a market cap of $25.28B and a P/E ratio of 25.35. LH moved +0.06% today. Year to date, LH is +23.96%; over the trailing twelve months it is +11.57%. Its 52-week range spans $209.38 to $341.80. Analyst consensus is strong buy with an average price target of $343.50. Rallies surfaces LH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for LH, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $312.15 |
| Market Cap | $25.28B |
| P/E Ratio | 25.35 |
| EPS | $12.17 |
| Dividend Yield | 0.72% |
| 52-Week High | $341.80 |
| 52-Week Low | $209.38 |
| Volume | 1.30K |
| Avg Volume | 0 |
| Revenue (TTM) | $14.35B |
| Net Income | $1.00B |
| Gross Margin | 28.88% |
13 analysts cover LH: 0 strong buy, 10 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $343.50.